改善ALK阳性非小细胞肺癌脑转移的治疗选择 - Suppr

Suppr

超能文献

Improving Treatment Options for Brain Metastases From ALK-Positive Non-Small-Cell Lung Cancer.

作者信息

Wardak Zabi, Choy Hak

机构信息

Zabi Wardak and Hak Choy, University of Texas Southwestern Medical Center, Dallas, TX.

出版信息

J Clin Oncol. 2016 Dec;34(34):4064-4065. doi: 10.1200/JCO.2016.69.9587. Epub 2016 Oct 24.

DOI:10.1200/JCO.2016.69.9587

PMID:27863198

Abstract

摘要

相似文献

Improving Treatment Options for Brain Metastases From ALK-Positive Non-Small-Cell Lung Cancer.改善ALK阳性非小细胞肺癌脑转移的治疗选择

J Clin Oncol. 2016 Dec;34(34):4064-4065. doi: 10.1200/JCO.2016.69.9587. Epub 2016 Oct 24.

Anaplastic lymphoma kinase inhibitors in brain metastases from ALK+ non-small cell lung cancer: hitting the target even in the CNS.间变性淋巴瘤激酶抑制剂在ALK阳性非小细胞肺癌脑转移中的应用：即使在中枢神经系统中也能精准靶向

Chin Clin Oncol. 2015 Jun;4(2):20. doi: 10.3978/j.issn.2304-3865.2015.05.03.

Brigatinib effective in ALK-positive non-small-cell lung cancer.布加替尼对ALK阳性非小细胞肺癌有效。

Lancet Oncol. 2017 Jun;18(6):e310. doi: 10.1016/S1470-2045(17)30342-X. Epub 2017 May 11.

Targeting brain metastases in ALK-rearranged non-small-cell lung cancer.针对 ALK 重排非小细胞肺癌的脑转移。

Lancet Oncol. 2015 Oct;16(13):e510-21. doi: 10.1016/S1470-2045(15)00013-3.

Crizotinib for the treatment of patients with advanced non-small cell lung cancer.克唑替尼用于治疗晚期非小细胞肺癌患者。

Drugs Today (Barc). 2012 Apr;48(4):271-82. doi: 10.1358/dot.2012.48.4.1769835.

Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial.阿来替尼对比克唑替尼用于治疗 ALK 阳性非小细胞肺癌患者（J-ALEX）：一项开放标签、随机、III 期临床试验。

Lancet. 2017 Jul 1;390(10089):29-39. doi: 10.1016/S0140-6736(17)30565-2. Epub 2017 May 10.

Resensitizing Refractory ALK+ NSCLC: A Case Study.使难治性ALK+非小细胞肺癌重新致敏：一项病例研究。

Cancer Discov. 2016 Mar;6(3):220-1. doi: 10.1158/2159-8290.CD-NB2016-009. Epub 2016 Jan 22.

Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases.克唑替尼治疗晚期ALK重排非小细胞肺癌合并脑转移患者的临床经验

J Clin Oncol. 2015 Jun 10;33(17):1881-8. doi: 10.1200/JCO.2014.59.0539. Epub 2015 Jan 26.

Targeted Therapy as an Alternative to Whole-Brain Radiotherapy in EGFR-Mutant or ALK-Positive Non-Small-Cell Lung Cancer With Brain Metastases.表皮生长因子受体突变或间变性淋巴瘤激酶阳性非小细胞肺癌伴脑转移患者中，靶向治疗作为全脑放疗的替代选择。

JAMA Oncol. 2017 Sep 1;3(9):1274-1275. doi: 10.1001/jamaoncol.2017.1047.

CNS Metastases in Patients With Non-Small-Cell Lung Cancer and ALK Gene Rearrangement.非小细胞肺癌伴ALK基因重排患者的中枢神经系统转移

J Clin Oncol. 2016 Jan 10;34(2):107-9. doi: 10.1200/JCO.2015.63.9682. Epub 2015 Nov 30.

引用本文的文献

Correlation between ALK+ non-small cell lung cancer targeted therapy and thrombosis: a systematic review and network meta-analysis.ALK+ 非小细胞肺癌靶向治疗与血栓形成的相关性：系统评价和网络荟萃分析。

BMJ Open. 2024 Sep 30;14(9):e078173. doi: 10.1136/bmjopen-2023-078173.

Real-world treatment and prognostic factors for survival in ALK+ non-small cell lung cancer (NSCLC) patients with brain metastases in China.中国 ALK+ 阳性非小细胞肺癌（NSCLC）脑转移患者的真实世界治疗方法和生存预后因素。

Thorac Cancer. 2023 Jan;14(3):237-245. doi: 10.1111/1759-7714.14739. Epub 2022 Nov 21.

Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer.针对转移性癌症的海马保护全脑放疗同步整合增敏的 II 期临床试验。

Neuro Oncol. 2020 Dec 18;22(12):1831-1839. doi: 10.1093/neuonc/noaa092.

Efficacy of Crizotinib for Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Patients with Brain Metastasis: A Multicenter, Retrospective Study in China.克唑替尼治疗中国晚期 ALK 重排非小细胞肺癌伴脑转移患者的疗效：一项多中心回顾性研究。

Target Oncol. 2019 Jun;14(3):325-333. doi: 10.1007/s11523-019-00637-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验